Stocks & ETFs Screener: 96 results (Pharmaceuticals)
| Symbol | Industry | Market Cap | Fund. Score | Div. Score | Tech. Score | P/E | Return 12m vs S&P 500 |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly |
Pharmaceuticals
Insulin, Diabetes, Oncology |
829B | 84.1% | 70.1% | 66.8% | 45.3 | 11.5% |
| JNJ Johnson & Johnson |
Pharmaceuticals
Pharmaceuticals, Medical Devices |
450B | 80.2% | 61.6% | 56.7% | 18.0 | 15.5% |
| ZEG AstraZeneca |
Pharmaceuticals
Oncology, Respiratory |
263B | 79.7% | 41.7% | 47.0% | 28.1 | 11.2% |
| AZN AstraZeneca |
Pharmaceuticals
Oncology, Cardiovascular |
262B | 85.1% | 39.7% | 75.1% | 28.1 | 21.6% |
| NVS Novartis |
Pharmaceuticals
Cardiovascular,Oncology,Immunology,.. |
243B | 87.1% | 59.6% | 95.2% | 17.3 | 15.5% |
| MRK Merck |
Pharmaceuticals
Keytruda, Gardasil, Januvia |
214B | 86.4% | 66.4% | -6.80% | 11.4 | -14.1% |
| NVO Novo Nordisk |
Pharmaceuticals
Insulin, Obesity Medication |
210B | 89.2% | 64.4% | -31.6% | 12.7 | -58.5% |
| PFE Pfizer |
Pharmaceuticals
Vaccines, Antivirals, Oncology |
139B | 63.7% | 70.6% | -34.0% | 14.2 | -9.13% |
| SAN Sanofi |
Pharmaceuticals
Immunology, Oncology, Neurology |
126B | 69.0% | 63.5% | 2.09% | 16.6 | -11.9% |
| SNY Sanofi |
Pharmaceuticals
Vaccines, Oncology, Immunology |
121B | 57.4% | 55.2% | 39.2% | 16.3 | -3.08% |
| GS71 GSK |
Pharmaceuticals
Vaccines, Specialty Medicines |
94.7B | 75.7% | 15.7% | 60.5% | 13.4 | 14.9% |
| GSK GlaxoSmithKline |
Pharmaceuticals
Vaccines, Specialty Medicines |
94.3B | 74.8% | 27.0% | 82.3% | 13.3 | 25.9% |
| BMY Bristol-Myers |
Pharmaceuticals
Oncology, Hematology, Immunology |
93.8B | 76.9% | 60.1% | -55.4% | 18.5 | -23.3% |
| MRK Merck KGaA |
Pharmaceuticals
Reagents, Drugs, Pigments |
56.9B | 57.2% | 38.0% | -57.5% | 16.7 | -28.3% |
| ZTS Zoetis |
Pharmaceuticals
Vaccines, Parasiticides |
53.0B | 88.0% | 68.9% | -49.0% | 20.2 | -39.1% |
| TAK Takeda |
Pharmaceuticals
Gastroenterology, Oncology, Rare |
44.0B | 60.9% | 36.3% | 34.3% | 192 | -3.56% |
| BAYN Bayer NA |
Pharmaceuticals
Pharmaceuticals, Consumer Health |
30.7B | 49.6% | 1.0% | 0.15% | - | 31.1% |
| TEVA Teva Pharma |
Pharmaceuticals
Generic Drugs, CNS Therapies |
27.5B | 46.8% | 18.1% | 71.0% | 39.3 | 32.4% |
| RPRX Royalty Pharma |
Pharmaceuticals
Royalties, Rare Disease, Cancer |
22.3B | 55.4% | 74.4% | 29.5% | 22.0 | 38.7% |
| IPN Ipsen |
Pharmaceuticals
Oncology, Neuroscience, Rare |
12.1B | 89.0% | 49.4% | 42.2% | 23.7 | 6.60% |
| VTRS Viatris |
Pharmaceuticals
Brand, Generic, Biosimilar |
11.7B | 29.1% | 60.0% | -11.4% | - | -22.8% |
| RDY Dr. Reddy’s |
Pharmaceuticals
Generics, APIs, Biologics |
11.3B | 81.7% | 48.6% | 33.8% | 17.0 | -15.8% |
| ELAN Elanco Animal |
Pharmaceuticals
Parasiticides, Vaccines |
10.7B | 43.6% | - | 55.4% | 307 | 36.1% |
| JAZZ Jazz |
Pharmaceuticals
Xywav, Xyrem, Epidiolex, Rylaze |
7.97B | 57.4% | - | -9.09% | - | -2.54% |
| CORT Corcept |
Pharmaceuticals
Hyperglycemia, Cushings |
7.61B | 83.4% | - | 86.6% | 64.5 | 17.8% |
| AXSM Axsome Therapeutics |
Pharmaceuticals
Antidepressant, Wake-Promoting |
6.96B | 33.5% | - | 83.4% | - | 23.3% |
| VIRP Virbac |
Pharmaceuticals
Vaccines, Antibiotics |
3.44B | 85.8% | 57.9% | 49.3% | 21.7 | -6.58% |
| AMRX Amneal |
Pharmaceuticals
Generics, Injectables |
3.14B | 58.5% | - | 76.0% | - | 12.0% |
| TARS Tarsus |
Pharmaceuticals
Eyelash Mite Therapy, Ocular |
2.90B | 38.1% | - | 69.4% | - | 36.9% |
| PBH Prestige Brand |
Pharmaceuticals
Analgesic, Diaper, Throat, Eye |
2.88B | 64.3% | 0.21% | -12.6% | 14.8 | -36.0% |
| SUPN Supernus |
Pharmaceuticals
ADHD, Epilepsy, Parkinson |
2.60B | 49.6% | - | 40.5% | - | 3.30% |
| BHC Bausch Health |
Pharmaceuticals
Gastroenterology, Dermatology |
2.44B | 47.9% | 4.23% | -39.9% | 25.4 | -33.8% |
| LQDA Liquidia |
Pharmaceuticals
Dry Powder Injectable Liposomal |
2.37B | 26.1% | - | 93.6% | - | 130% |
| OCUL Ocular Therapeutix |
Pharmaceuticals
Dexamethasone, Axitinib, Travoprost |
2.31B | 27.2% | - | 62.8% | - | -7.32% |
| DMP Dermapharm Holding |
Pharmaceuticals
Branded Generics, OTC |
2.11B | 70.0% | 50.4% | -38.7% | 16.6 | -3.11% |
| ANIP ANI Pharmaceuticals |
Pharmaceuticals
Injectables, Softgels, Cortrophin |
2.02B | 70.4% | - | 93.2% | 56.5 | 24.1% |
| PRGO Perrigo |
Pharmaceuticals
OTC, Vitamins, Infant Formula |
1.99B | 43.8% | 72.3% | -76.4% | - | -52.3% |
| AVDL Avadel |
Pharmaceuticals
Hypnotic, Narcolepsy, Lymphatic |
1.83B | 60.7% | - | 75.1% | - | 40.5% |
| HRMY Harmony |
Pharmaceuticals
Wakix, Pitolisant, BP1.15205 |
1.81B | 91.7% | - | -38.8% | 9.91 | -11.0% |
| PAHC Phibro Animal |
Pharmaceuticals
Animal Health, Medicated Feed |
1.77B | 59.7% | 34.1% | 80.8% | 26.2 | 58.2% |
| OGN Organon |
Pharmaceuticals
Contraception, Fertility |
1.75B | 56.4% | 49.9% | -83.8% | 2.51 | -56.2% |
| TERN Terns |
Pharmaceuticals
TKI, THR-Agonist, GLP-1-Agonist |
1.62B | 33.4% | - | 57.5% | - | 168% |
| INVA Innoviva |
Pharmaceuticals
Antibiotics, Respiratory |
1.56B | 75.5% | 2.39% | 62.1% | 12.6 | -3.03% |
| TLRY Tilray |
Pharmaceuticals
Cannabis,Beverage,Wellness,Distribu.. |
1.39B | 44.9% | - | -56.7% | - | -31.1% |
| AMLX Amylyx |
Pharmaceuticals
Avexitide, Amx0035, Amx0114 |
1.35B | 21.5% | - | -7.84% | - | 92.0% |
| TRVI Trevi Therapeutics |
Pharmaceuticals
Investigational, Therapy, Chronic |
1.34B | 32.1% | - | 91.7% | - | 252% |
| COLL Collegium |
Pharmaceuticals
Oxycodone, Hydrocodone, Opioid |
1.34B | 75.3% | - | 77.0% | 26.0 | 34.9% |
| EVT Evotec SE |
Pharmaceuticals
Drug Discovery, Small Molecules |
1.31B | 33.3% | - | -80.9% | - | -44.1% |
| HROW Harrow Health |
Pharmaceuticals
Pharmaceutical,Imprinted,Drogs,Oint.. |
1.26B | 41.6% | - | 53.5% | - | -35.8% |
| WVE Wave Life Sciences |
Pharmaceuticals
RNA Editing, GalNAc-Conjugated |
1.25B | 31.3% | - | 5.16% | - | -62.7% |
| NKTR Nektar Therapeutics |
Pharmaceuticals
Treg Stimulator, PEG-CSF1, TNFR2 |
1.23B | 28.4% | - | 19.0% | - | 147% |
| XERS Xeris |
Pharmaceuticals
Injectable, Glucagon, Diabetes |
1.23B | 57.9% | - | 86.1% | - | 102% |
| RAPP Rapport |
Pharmaceuticals
Antiepileptic, Analgesic |
1.22B | 32.0% | - | 27.8% | - | -0.88% |
| AMPH Amphastar P |
Pharmaceuticals
Enoxaparin, Insulin, Glucagon |
1.10B | 70.6% | - | -25.3% | 10.6 | -49.1% |
| ELVN Enliven |
Pharmaceuticals
Kinase,Inhibitors,Oncology,Pipeline |
1.04B | 29.0% | - | -17.9% | - | -31.0% |
| EYPT Eyepoint |
Pharmaceuticals
Therapeutics, Retinal, Durasert |
986M | 33.3% | - | 55.1% | - | -6.09% |
| PHAT Phathom |
Pharmaceuticals
GERD,Heartburn,H.Pylori,Esophagitis |
977M | 65.8% | - | 37.0% | - | 33.7% |
| PCRX Pacira BioSciences |
Pharmaceuticals
Bupivacaine,Anesthetic,Injectable |
961M | 47.9% | - | -28.8% | - | 26.1% |
| CRON Cronos |
Pharmaceuticals
Cannabis, Edibles, Oils, Vapes |
950M | 48.2% | - | 1.12% | 22.6 | 0.34% |
| SEPN Septerna, Common |
Pharmaceuticals
GPCR, Oral, Small-Molecule |
853M | 34.0% | - | 1.08% | - | -27.2% |
| CRMD CorMedix |
Pharmaceuticals
Antibiotic, Dialysis, Catheter |
843M | 89.9% | - | 58.1% | 13.8 | -13.3% |
| ARVN Arvinas |
Pharmaceuticals
PROTAC, Cancer, Breast, Prostate |
753M | 40.7% | - | -79.1% | - | -64.9% |
| AQST Aquestive |
Pharmaceuticals
Epinephrine Film, Apomorphine |
748M | 51.4% | - | 63.7% | - | -3.66% |
| TBPH Theravance |
Pharmaceuticals
COPD, Nebulizer, Ampreloxetine |
743M | 82.9% | - | 58.9% | 61.5 | 62.8% |
| VTYX Ventyx Biosciences |
Pharmaceuticals
VTX958, Tamuzimod, VTX2735 |
626M | 36.4% | - | -13.9% | - | 315% |
| MAZE Maze Therapeutics |
Pharmaceuticals
Precision Medicine, APOL1 |
525M | 36.6% | - | 90.1% | - | 77.6% |
| NMRA Neumora |
Pharmaceuticals
Kappa Antagonist, Agitation Drug |
475M | 32.8% | - | -63.7% | - | -78.1% |
| ETON Eton |
Pharmaceuticals
Hormone, Enzyme, Metabolic |
474M | 52.1% | - | 80.2% | - | 39.8% |
| SIGA SIGA Technologies |
Pharmaceuticals
Antiviral, Smallpox, TPOXX, Health |
468M | 83.7% | 87.9% | 18.0% | 6.35 | -10.8% |
| SNDL SNDL |
Pharmaceuticals
Cannabis, Liquor, Pre-Rolls |
458M | 49.7% | - | -33.5% | - | -23.9% |
| EOLS Evolus |
Pharmaceuticals
Botulinum Toxin, Hyaluronic Acid |
457M | 26.0% | - | -34.3% | - | -47.2% |
| OMER Omeros |
Pharmaceuticals
Narsoplimab, OMS1029, Zaltenibart |
448M | 38.1% | - | 15.0% | - | 31.6% |
| FULC Fulcrum |
Pharmaceuticals
Pociredir, Losmapimod, Fetal |
441M | 23.2% | - | 36.8% | - | 117% |
| CGC Canopy Growth |
Pharmaceuticals
Dried Flower, Extracts, Edibles |
395M | 20.2% | - | -84.3% | - | -75.5% |
| ANRO Alto Neuroscience |
Pharmaceuticals
Bipolar Depression, Major |
357M | 44.2% | - | -26.0% | - | 120% |
| CTNM Contineum |
Pharmaceuticals
PIPE-791, PIPE-307, CTX-343 |
319M | 30.6% | - | -59.7% | - | -48.9% |
| AARD Aardvark |
Pharmaceuticals
ARD-101, ARD-201, Obesity |
284M | 34.7% | - | -39.0% | - | -31.7% |
| ALTS ALT5 Sigma |
Pharmaceuticals
Trading, Payments, Tokenization |
265M | 27.0% | 1.0% | -10.1% | - | -31.6% |
| BIOA BioAge Labs |
Pharmaceuticals
Azelaprag, BGE-102, Obesity |
260M | 51.7% | - | -56.2% | 0.53 | -66.4% |
| AVIR Atea |
Pharmaceuticals
Antiviral, Oral, Hepatitis |
260M | 44.4% | - | -41.2% | - | -19.8% |
| ACB Aurora Cannabis |
Pharmaceuticals
Dried Cannabis, Cannabis Oil |
257M | 60.5% | - | -36.9% | - | -15.1% |
| ACRS Aclaris |
Pharmaceuticals
JAK Inhibitor, TSLP Antibody |
251M | 29.5% | - | -62.9% | - | -16.5% |
| TVRD Tvardi |
Pharmaceuticals
Oral, STAT3, Inhibitor, Phase-2 |
242M | 59.6% | - | -56.6% | - | -69.1% |
| MDWD Mediwound |
Pharmaceuticals
Eschar,Burn,Therapy,Tissue,Biopharm.. |
225M | 34.1% | - | 41.5% | - | -2.79% |
| OGI OrganiGram Holdings |
Pharmaceuticals
Cannabis,Flower,Pre-Rolls,Vapes,Edi.. |
205M | 41.3% | - | -36.4% | 153 | -14.4% |
| ELTX Elicio Therapeutics |
Pharmaceuticals
Vaccine, Lymph Node, Preclinical |
152M | 47.0% | - | 23.9% | - | 53.8% |
| MIST Milestone |
Pharmaceuticals
Etripamil, Calcium Channel |
145M | 22.3% | - | -44.5% | - | -9.34% |
| SAVA Cassava Sciences |
Pharmaceuticals
Alzheimers Drug, Pipeline |
143M | 33.9% | 0.17% | -62.9% | - | -89.8% |
| IRD Opus Genetics |
Pharmaceuticals
Gene Therapy, Retinal Disease |
130M | 37.4% | - | -6.58% | - | 50.4% |
| SCLX Scilex Holding |
Pharmaceuticals
Topical, Non-Opioid, Pain Relief |
122M | 66.9% | - | -64.2% | - | -39.4% |
| RLMD Relmada |
Pharmaceuticals
Controlled-Release, Formulation |
66.7M | 49.9% | - | -11.2% | - | -46.5% |
| TELO Telomir |
Pharmaceuticals
Small Molecule, Degenerative |
44.7M | 45.0% | - | -93.9% | - | -71.3% |
| MIRA MIRA |
Pharmaceuticals
Ketamine Analog, Marijuana Capsule |
30.4M | 39.8% | - | -30.1% | - | -24.6% |
| ITRM Iterum Therapeutics |
Pharmaceuticals
Oral Penem, Intravenous Penem, UTI |
28.8M | 29.0% | - | -86.7% | - | -65.6% |
| CTXR Citius |
Pharmaceuticals
Immunotherapy, Antibiotic |
25.3M | 35.1% | - | -84.1% | - | -90.8% |
| ASBP Aspire BioPharma |
Pharmaceuticals
Sublingual, Aspirin, Melatonin |
20.2M | 34.7% | - | -80.9% | - | -99.2% |